medigraphic.com
SPANISH

Revista Mexicana de Periodontología

ISSN 2007-4360 (Print)
Asociación Mexicana de Periodontología, Colegio de Periodoncistas A.C
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2024, Number 1-3

<< Back Next >>

Rev Mex Periodontol 2024; 15 (1-3)

Analysis of novel heterosteroids as potential modulators of inflammation in periodontal disease: an in silico approach by molecular docking

Hernández-León CR, Cárdenas-García M, Hernández-Linares MG, Bernès SJ
Full text How to cite this article 10.35366/121224

DOI

DOI: 10.35366/121224
URL: https://dx.doi.org/10.35366/121224

Language: Spanish
References: 7
Page: 7-11
PDF size: 340.93 Kb.


Key words:

in silico, molecular docking, inflammation, periodontal disease.

ABSTRACT

Introduction: periodontal disease is a multifactorial chronic inflammation leading to destruction of the dental support system. Limitations of current therapies have prompted the search for new options. At the Botanical Garden of Instituto de Ciencias de la Universidad Autónoma de Puebla (ICUAP), heterosteroids derived from hecogenin, sarsasapogenin and diosgenin have been developed. Their anti-inflammatory potential has been evaluated by molecular docking. Objective: to evaluate novel heterosteroids as potential modulators of inflammation in periodontal disease by an in silico approach using molecular docking to identify potential therapeutic targets. Material and methods: PRISMA diagram was applied to systematize the information and select therapeutic targets. In silico simulation was performed with AutoDock 4.2.6©, evaluating the interaction of 62 heterosteroids with 69 key proteins. Results: 18 proteins were identified with significant interactions among 69 evaluated. Of the 69 heterosteroids, 39 showed promising interactions. A total of 127 molecular couplings were performed, highlighting 9 compounds with higher affinity, with D7, D12 and D13 being the most relevant. D12 stands out for its efficacy and low toxicity demonstrated in cancer studies. Conclusion: heterosteroids D7, D12, D13, AcO3Lax, 30xLax, Pseudodione, S5, H10 and H13 are promising as anti-inflammatory agents for periodontal disease, suggesting future in vitro studies.


REFERENCES

  1. Holmstrup P, Plemons J, Meyle J. Non-plaque-induced gingival diseases. J Periodontol. 2018; 45 Suppl 20: S28-S45.

  2. Murakami S, Mealey BL, Mariotti A, Chapple ILC. Dental plaque-induced gingival conditions. J Periodontol. 2018; 89 Suppl 1: S17-S27.

  3. Shalaby R, Elmahdy A, Mikhail C. The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study. BMC Oral Health. 2023; 23(1): 786.

  4. Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol. 2008; 79 (8 Suppl): 1601-1608.

  5. Pérez L. Efecto anabólico de análogos de brasinoesteroides en células de músculo esquelético: una aproximación in silico e in vitro. Puebla: Benemérita Universidad Autónoma de Puebla; 2022.

  6. Onodera K, Satou K, Hirota H. Evaluations of molecular docking programs for virtual screening. J Chem Inf Model. 2007; 47 (4): 1609-1618.

  7. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010; 31 (2): 455-461.




Figure 1
Figure 2
Figure 3
Figure 4

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Periodontol. 2024;15